Arrowhead Pharmaceuticals, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,260,380

Value ($000)

83,677

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	83,677	0.0%	1,260,380	12/31/2025
2025 Q3	11/14/2025	60,685	0.0%	1,759,489	9/30/2025
2025 Q2	8/14/2025	42,412	0.0%	2,684,317	6/30/2025
2025 Q1	5/19/2025	60,962	0.0%	4,785,062	3/31/2025
2024 Q4	2/14/2025	37,790	0.0%	2,010,129	12/31/2024
2024 Q3	11/14/2024	41,728	0.0%	2,154,250	9/30/2024
2024 Q2	8/14/2024	59,521	0.0%	2,290,154	6/30/2024
2024 Q1	5/15/2024	26,710	0.0%	933,900	3/31/2024
2023 Q4	2/14/2024	29,110	0.0%	951,294	12/31/2023
2023 Q3	11/13/2023	19,907	0.0%	740,882	9/30/2023
2023 Q2	8/11/2023	13,639	0.0%	536,965	6/30/2023
2023 Q1	5/15/2023	13,639	0.0%	536,965	3/31/2023
2022 Q4	2/14/2023	20,196	0.0%	497,921	12/31/2022
2022 Q3	11/14/2022	2,854	0.0%	86,360	9/30/2022
2022 Q2	8/12/2022	3,863	0.0%	109,725	6/30/2022
2022 Q1	5/16/2022	5,238	0.0%	113,886	3/31/2022
2021 Q4	2/14/2022	6,438	0.0%	97,109	12/31/2021
2021 Q3	11/15/2021	6,149	0.0%	98,492	9/30/2021
2021 Q2	8/16/2021	7,260	0.0%	87,661	6/30/2021
2021 Q1	5/14/2021	6,065	0.0%	91,461	3/31/2021
2020 Q4	3/1/2021	9,023	0.0%	117,596	12/31/2020
2020 Q3	11/13/2020	4,569	0.0%	106,119	9/30/2020
2020 Q2	8/14/2020	4,542	0.0%	105,174	6/30/2020
2020 Q1	5/15/2020	2,558	0.0%	88,897	3/31/2020
2019 Q4	2/14/2020	5,715	0.0%	90,094	12/31/2019